Clinical Trial

Silver Sulfadiazine With Hyaluronic Acid Versus Silver Sulfadiazine Alone in Partial-Thickness Burns

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Partial-thickness burns are commonly treated with topical silver sulfadiazine; however, its use may delay epithelialization due to cytotoxic effects on regenerating cells. Hyaluronic acid has biological properties that may enhance wound healing when combined with silver sulfadiazine. This study aims to compare the time to re-epithelialization between silver sulfadiazine combined with hyaluronic acid and silver sulfadiazine alone in patients with bilateral partial-thickness burns using an intra-patient randomized controlled design.
Trial Details
NCT Number NCT07367087
Lead Sponsor Dr Muhammad Naveed Shahzad
Conditions Partial-Thickness Burn, Thermal Burn
Enrollment 30 participants
Start Date 2026-02
Primary Completion 2026-08 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-26